Tocqueville Asset Management’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
Tocqueville Asset Management's ONCY Position: Q3 2026 in Review
Tocqueville Asset Management increased its Oncolytics Biotech (ONCY) stake by 6.8% in Q3 2026, buying an estimated $8.12K and bringing the position to 157,000 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #545.
Tocqueville Asset Management first reported a position in ONCY in Q4 2025 and has held it in 4 quarters since. The position peaked at $140K in Q2 2026. 77 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.
- Tocqueville Asset Management held 157,000 shares of Oncolytics Biotech worth $105K as of Q3 2026.
- Tocqueville Asset Management bought 10,000 Oncolytics Biotech shares in Q3 2026, an estimated $8.12K.
- Oncolytics Biotech made up ﹤0.01% of Tocqueville Asset Management's portfolio in Q3 2026, its #545 holding.
- Tocqueville Asset Management first reported a position in Oncolytics Biotech in Q4 2025 and has held it in 4 quarters since.
- Tocqueville Asset Management's Oncolytics Biotech position peaked at $140K in Q2 2026.
- 77 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.
Based on Tocqueville Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.